For citations:

Davidyan S.Y., Kiryukhina N.A., Rybakova D.V. NEW IL-6 INHIBITOR OLOKIZUMAB (ARTLEGIA) IN ROUTINE CLINICAL PRACTICE IN PATIENTS WITH MODERATE AND SEVERE RHEUMATOID ARTHRITIS. Bulletin of Pirogov National Medical & Surgical Center. 2024;19(1):71-77. (In Russ.) https://doi.org/10.25881/20728255_2024_19_1_71